Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2011
08/04/2011CA2788546A1 Method and device for producing 99mtc
08/04/2011CA2786655A1 Radioimmunoconjugates that blind human cd37 and uses thereof
08/03/2011EP2351758A1 Metal complexes, a method for preparing same, radiopharmaceutical means based thereon
08/03/2011EP2350000A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
08/03/2011EP2349352A1 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazinoý4,5-b¨indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
08/03/2011EP2349351A2 Imaging and radiotherapy methods
08/02/2011US7989649 Tumor imaging compounds
08/02/2011US7989589 Compstatin analogs with improved activity
08/02/2011US7989417 Linkers for radiopharmaceutical compounds
08/02/2011US7989415 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome
08/02/2011US7989414 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/02/2011US7988969 Treatment for central nervous system disorders
08/02/2011US7988949 Nanoparticles for protein drug delivery
08/02/2011US7988612 Carrier-free 103Pd brachytherapy seeds
08/02/2011CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
08/02/2011CA2419420C Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
07/2011
07/28/2011WO2011091113A2 Detection of early-stage pancreatic adenocarcinoma
07/28/2011WO2011090492A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
07/28/2011US20110184418 Unsealed, Non-Colloidal Radiopharmaceutical Compositions and Methods for Treatment of Abnormal Tissue
07/28/2011US20110184330 Inactivation of smooth muscle tissue
07/28/2011US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof
07/28/2011US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells
07/28/2011US20110182812 Imaging Agents for Detecting Neurological Disorders
07/28/2011US20110182811 Nucleotide sequence encoding a modulator of nf-kb
07/28/2011US20110182810 Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration
07/28/2011US20110182809 Method of Promoting Neurogenesis
07/28/2011US20110182808 Strontium-82/Rubidium-82 Generator, Method for Producing a Rubidium-82 Comprising Diagnostic Agent, Said Diagnostic Agent and Its Use in Medicine
07/28/2011US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent
07/28/2011US20110182806 Systems and methods for particle radiation enhanced delivery of therapy
07/28/2011US20110182805 Nanoparticle fabrication methods, systems, and materials
07/28/2011CA2787753A1 Detection of early-stage pancreatic adenocarcinoma
07/28/2011CA2787074A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
07/27/2011EP2348052A2 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
07/27/2011EP2348037A1 Method for introducing dota
07/27/2011EP2347771A1 Peptide-based compounds for targeted imaging
07/27/2011EP2347770A2 Process for producing an injectable pharmaceutical preparation
07/27/2011EP1587550B1 Methods and compositions for administering therapeutic and diagnostic agents
07/27/2011EP1569690B1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent
07/27/2011CN102137849A Cyclic polyamines for binding phosphatidylserine
07/27/2011CN102133410A Immunotherapy of B cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins
07/26/2011US7985836 Antimicrobial peptides and methods of identifying the same
07/26/2011US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
07/26/2011US7985425 Non-pharmacological method for treating depression, skin disorders and improving overall health and wellness
07/26/2011US7985401 Peptides whose uptake by cells is controllable
07/26/2011CA2485385C Lyophilized edible food incorporating a marker
07/26/2011CA2479514C Tumor imaging compounds
07/21/2011WO2011087823A1 Aldehydes for in vivo imaging of aldh in cancer stem cells
07/21/2011WO2011028935A3 Methods of treating mitochondrial disorders using metalloporhyrins
07/21/2011WO2010121153A3 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites
07/21/2011US20110177008 Paramagnetic metal-nanodiamond conjugates
07/21/2011US20110176998 Imaging and therapy of virus-associated tumors
07/21/2011US20110176997 Method to make porous materials and their applications
07/21/2011US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
07/21/2011US20110176995 Diagnosis and treatment of cancer using anti-gpr49 antibody
07/21/2011US20110176994 Buoyant Polymer Particles for Delivery of Therapeutic Agents to the Central Nervous System
07/21/2011US20110176993 Vegf polymorphisms and anti-angiogenesis therapy
07/20/2011EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof
07/20/2011EP2344040A1 Molecular imaging
07/20/2011CN102126985A 18F labelled precursor compound and preparation method and application thereof
07/20/2011CN101775039B Preparation method and application of 99mTc-marked hydrazino nicotinamide-folate complexs
07/20/2011CN101505803B Composition for diagnosing amyloid-related disease
07/20/2011CN101484190B Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
07/20/2011CN101301496B Biodegradable and absorbable polymer superfine fibre film with radioactive nuclide marker and preparation and use thereof
07/20/2011CN101210016B Heterocycle-fused morphinans compounds, preparation method and use thereof
07/20/2011CA2782658A1 Improved biomarker generator
07/19/2011US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
07/19/2011US7981858 Methods of using zinc containing compounds to improve ocular health
07/19/2011CA2188560C Compositions comprising dna damaging agents and p53
07/14/2011WO2011084571A2 Azide derivatives for phototherapy
07/14/2011WO2011083845A1 Targeting agent for tumor site
07/14/2011US20110172157 Somatostatin analogues
07/14/2011US20110172139 Peptides whose uptake by cells is controllable
07/14/2011US20110171130 A3 adenosine receptor antagonists and partial agonists
07/14/2011US20110171129 Molecular Probe Precursor for Imaging of Pancreatic Islet, and Use Thereof
07/14/2011US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
07/14/2011US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/14/2011US20110171126 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
07/14/2011US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
07/14/2011US20110171124 In situ methods for monitoring the EMT status of tumor cells in vivo
07/14/2011US20110171123 In Vivo Biofilm Infection Diagnosis and Treatment
07/14/2011US20110171122 Methods and compositions for the detection of cancer
07/13/2011EP2343047A2 Optically-active nanoparticles for use in therapeutic and diagnostic methods
07/13/2011EP2342197A1 Radiolabelled inhibitors of the glycine 1 transporter
07/13/2011EP2341945A2 Methods and therapies for treating inflammatory conditions with exposed collagen
07/13/2011EP2341944A2 Conjugates of hexose and metal coordinating compounds for imaging purposes
07/13/2011EP2341909A1 Novel substituted azabenzoxazoles
07/13/2011EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof
07/13/2011CN1871233B Novel chelating agents and chelates and their use
07/13/2011CN102123739A Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules
07/13/2011CN102120039A Use of carbon-11 marked N-methyldopamine hydrochloride in preparation of positron medicinal imaging agent
07/13/2011CN101347626B Vascularized specific polypeptide for marking tumor by radioactive nucleus and uses thereof
07/12/2011US7977373 Prodrugs of ion channel modulating compounds and uses thereof
07/12/2011US7976855 Metal ion modified high surface area materials for odor removal and control
07/12/2011US7976824 Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis
07/12/2011US7976823 Ferromagnetic particles and methods
07/12/2011US7976743 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure
07/12/2011CA2555435C Alpha-emitting hydroxyapatite particles
07/07/2011WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
07/07/2011US20110166320 Somatostatin analogues
07/07/2011US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 243